secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001104659-23-090511
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics amends bylaws to adopt advance notice provisions for stockholder proposals
--------------------------------------------------------------------------------

- Board amended and restated bylaws effective October 3, 2023.
- New Section 1.11 requires advance notice for director nominations and other stockholder proposals.
- Notice must be delivered at least 120 days before anniversary of prior year's annual meeting.
- Stockholder notice must comply with detailed requirements in Section 1.11(c) and (e).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465923090511/0001104659-23-090511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465923090511/tm2323521d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-090511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer